REG - AstraZeneca PLC - Filing of Form 20-F with SEC <Origin Href="QuoteRef">AZN.L</Origin>

AstraZenecaAnnouncement

08/03/2016 18:30

RNS Number : 4665R
AstraZeneca PLC
08 March 2016
FILING OF ANNUAL REPORT ON FORM 20-F WITH THE US SECURITIES AND EXCHANGE COMMISSION
AstraZeneca PLC (the Company) announced today that it filed its Annual Report on Form 20-F with the US Securities and Exchange Commission (SEC). The document is available for viewing on the SEC website at www.sec.gov and also on the Company's website at www.astrazeneca.com. The Company will send any holder of the Company's securities, upon request, a hard copy of the Company's complete audited financial statements free of charge. Requests may be made by writing to the Company Secretary, AstraZeneca PLC, 2 Kingdom Street, London W2 6BD.
A C N Kemp
Company Secretary
8 March 2016

This information is provided by RNS
The company news service from the London Stock Exchange
  END
MSCSSWFAAFMSESD